START Midwest, LLC — Grand Rapids, Michigan

START Midwest, LLC is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

START Midwest, LLC has participated in 7 clinical trials with 6 currently active.

Therapeutic areas: Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer.

Sponsors: Syros Pharmaceuticals, Genmab, Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Midwest, LLC?

START Midwest, LLC has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Midwest, LLC conducted?

START Midwest, LLC has 7 clinical trials on record, with 6 currently active. Their work covers Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer.

Is START Midwest, LLC accredited by Crixeo Health?

START Midwest, LLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Midwest, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.